|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online October 24, 2007
doi: 10.1242/10.1242/jcs.011130
Research Article |


1 Heidelberg University Biochemistry Center, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
2 Department of Virology, University of Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany
3 Advanced Light Microscopy Facility, EMBL, Meyerhofstr. 1, Heidelberg, Germany
4 Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany
5 Electron Microscopy Facility, University Ulm, 89069 Ulm, Germany
Authors for correspondence (e-mails: walter.nickel{at}bzh.uni-heidelberg.de; oliver_fackler{at}med.uni-heidelberg.de)
Accepted 22 August 2007
| Summary |
|---|
|
|
|---|
Key words: SH4 domain, Membrane blebbing, Cell invasion, Src, Rocka
| Introduction |
|---|
|
|
|---|
The PM of eukaryotic cells is subject to dynamic reorganizations that are mediated by the submembranous cortical cytoskeleton under the control of specific small Rho GTPase-regulated signalling cascades. Depending on the GTPase involved, such PM dynamization leads to the active generation of cell protrusions, such as, for example, lamellipodia and filopodia (Hall, 1998
). In addition, localized destabilization of the cortical actin meshwork results in the formation of rounded cell protrusions generated by the osmotic pressure of the cell interior; these protrusions are referred to as PM blebs (Charras et al., 2005
; Cunningham, 1995
; Sheetz et al., 2006
). Following bleb formation, contractile acto-myosin force is generated to drive bleb retraction. Multiple, mechanistically and functionally distinct types of PM blebs have been described, including blebs induced during apoptosis or necrosis (Coleman et al., 2001
; Lane et al., 2005
; Mills et al., 1998
; Sebbagh et al., 2001
; Torgerson and McNiven, 1998
), cytokinesis (Fishkind et al., 1991
) and cytokine secretion (MacKenzie et al., 2001
). Furthermore PM blebs have been suggested to facilitate cell motility of tumour cells in 3D matrices (Sahai and Marshall, 2003
).
Here, we studied the SH4 domains of several Src kinases and of the Leishmania parasite virulence factor hydrophilic acylated surface protein (HASPB) (Denny et al., 2000
; Stegmayer et al., 2005
). Unexpectedly, we found that expression of SH4 domains causes the reorganization of the PM to produce highly dynamic non-apoptotic membrane blebs. PM blebbing was found to be a conserved activity of Src kinase SH4 domains and depends on endogenous Src activity. Because SH4-domain-induced PM blebbing correlated with enhanced cell invasion in 3D matrices, these results suggest an active role of SH4 domains in the oncogenic properties of Src kinases.
|
| Results |
|---|
|
|
|---|
myr-HASPB-GFP localized diffusely in the cytoplasm and the nucleus in a pattern reminiscent of GFP alone (compare Fig. 1Ae,f with Fig. 1Bc) (see also Denny et al., 2000
pal-HASPB-GFP (which retains its myristoylation) accumulated at perinuclear membranes [most probably the Golgi apparatus (Denny et al., 2000
|
|
myr-HASPB-GFP-expressing control cells (supplementary material Movie 3 and Fig. S3B). In line with previous characterizations of PM blebbing in M2 melanoma cells (Charras et al., 2005
(MacKenzie et al., 2001
SH4-domain-induced membrane blebbing is controlled by Rho
To gain insight into the cellular signal transduction pathways that govern SH4-domain-mediated PM blebbing, we addressed the involvement of the small GTPases Rho, Rac and Cdc42. The SH4 domain of HASPB fused to the fluorescent mCherry protein (N18-HASPB-mCherry) was co-expressed with GFP fusion proteins of wild-type GTPases, dominant-negative (N17) Rac or Cdc42, or C3 transferase, to inhibit the activity of Rho. Only C3-mediated inhibition of Rho significantly reduced bleb formation (Fig. 4). Even though no blebbing occurred, N18-HASPB-GFP still localized to the PM in the presence of C3 (data not shown), indicating that SH4 domains are targeted to the PM in a Rho-independent manner but use a signalling cascade downstream of Rho to trigger membrane blebbing at the PM.
|
Requirements for SH4-induced plasma membrane blebbing
The Rho effector kinase Rock provides acto-myosin contractility required for most types of PM blebbing described (Leverrier and Ridley, 2001
; Morelli et al., 2003
; Sahai and Marshall, 2003
). Consistently, blocking Rock activity by the specific inhibitor Y-27632 potently interfered with HASPB-mediated PM blebbing (Fig. 5A,C). Similar results were obtained using blebbistatin (Straight et al., 2003
), a drug that specifically interferes with the ATPase activity of the myosin II motor protein. Analysis of the F-actin network demonstrated some enrichment of F-actin at the limiting membrane and, in particular, at the neck of the blebs. By contrast, no specific association of microtubuli with the blebs was observed (Fig. 5B). Nevertheless, depolymerization of either F-actin or microtubules by cytochalasin D or nocodazole, respectively, potently abrogated HASPB-induced PM blebbing (Fig. 5A-C). Together, these results show that the induction of PM blebs by the HASPB SH4 domain depends on the integrity of both F-actin and microtubule networks, and requires myosin II function. These results further reveal a novel link between Rho-Rock activity and SH4 domains.
|
myr-HASPB-GFP cells invaded into the matrigel with significantly higher efficiency (Fig. 6). The invasiveness of N18-HASPB-GFP cells closely matched that of metastatic MDA-MB-435 human breast carcinoma cells, which served as a positive control. Thus, SH4-domain overexpression promotes cell invasion. Importantly, imaging within the matrigel revealed a rounded morphology with prominent cell protrusions for all SH4-domain-expressing cells, most of which displayed pronounced dynamic PM blebbing (see supplementary material Movies 4, 5). Although we cannot exclude that other SH4-domain effects are involved in cell invasion, these results suggest that the induced blebbing is instrumental for SH4-domain-induced 3D cell motility.
|
myr-GFP as a control (Fig. 7C,D). Control cells displayed some membrane ruffling at the periphery as well as at the dorsal surface and were decorated by numerous microvilli-like protrusions, but no PM blebs were observed (Fig. 7D). These cells were indistinguishable from mock-transfected control cells (data not shown). By sharp contrast, an abundant fraction of cells in cultures transfected with the N18-Yes-GFP expression construct was positive for a large number of blebs directly emanating from the PM at cell edges as well as at the dorsal surface, which additionally contained microvilli-like structures (Fig. 7C). Consistent with the above-presented fluorescence microscopy, blebs were variable in size and number, ranging from a few up to more than 100 per cell. Peripheral membrane ruffling also appeared slightly increased in such bleb-positive cells. Thus, PM blebbing is a conserved activity of Src kinase SH4 domains and the resulting blebs can cover large areas of the dorsal surface of SH4-domain-expressing cells.
|
Requirement for endogenous Src activity for SH4-domain-induced plasma membrane blebbing
To test whether membrane blebbing activity via SH4 domains involves the activity of the Src kinases, we analyzed the effects of inhibition of endogenous Src on SH4-domain-mediated PM blebbing (Fig. 8). The two well-established, structurally distinct specific Src kinase inhibitors PP1 and SU5565 were added to CHO cells expressing N18-HASPB-GFP (Fig. 8, left) or N18-Fyn-GFP (Fig. 8, right). Treatment with both inhibitors at 1 µM already markedly reduced PM blebbing. When 10 µM inhibitor was used, blebbing inhibition was within the range of that observed with addition of the Rock inhibitor Y-27632. Similar results were obtained for the SH4 domains of Src, Yes and Lck (data not shown). We conclude that endogenous Src activity is crucial for PM blebbing through SH4 domains.
|
|
|
|
| Discussion |
|---|
|
|
|---|
Non-apoptotic cells generally fail to display PM blebbing under regular cell-culture conditions. In addition to the previously described M2 cells (Charras et al., 2005
; Cunningham, 1995
; Sheetz et al., 2006
), the present study introduces SH4 domains as novel regulators that induce constitutive PM blebbing. Assuming that similar blebbing programmes are activated in SH4-domain-expressing and M2 cells, different cues can activate common machineries with efficiencies that probably depend on the cellular environment. Physiologically, such induction is observed with tumour cells that do not display membrane blebs when cultured in 2D but activate blebbing motility in a 3D environment (Sahai and Marshall, 2003
). SH4-domain overexpression, however, resulted in the constitutive activation of blebbing in 2D that was maintained in a 3D environment, possibly by mimicking the constitutive activation of a cellular pathway. Because full-length SH4-domain-containing proteins such as HASPB and Lck also triggered PM blebbing in a manner dependent on SH4-domain integrity, we favour the hypothesis that such pathways rely on the function of SH4 domains from endogenous proteins.
Because SH4-mediated bleb induction correlated with increased cell invasion and 3D cell cultures are largely refractory to in-depth molecular analyses, we took advantage of SH4-expressing cells to study the molecular mechanisms of PM blebbing. Our attempts to define the determinants for PM blebbing in SH4 domains revealed that bleb induction requires PM localization of the SH4 domain. Based on the variety of SH4 domains capable of PM bleb induction, the mode of acylation [e.g. myristoylation only (Src) or in combination with palmitoylation (Yes)] does not determine blebbing activity. Sequence comparison of the various SH4 domains analyzed failed to reveal a common signature motif (supplementary material Fig. S4) and, thus far, we could not generate a SH4-domain mutant that does not induce blebbing but is transported to the PM (data not shown). The identification of such a mutant will be an important aim of future studies.
In terms of cellular machinery, our results identify endogenous Src activity as a factor that is crucially involved in bleb formation. Because inhibition of Src did not affect PM localization of the SH4 domains (data not shown), it probably represents a downstream effector. This also implies that SH4 domains might exert biological activities beyond their membrane-targeting function. Our localization analyses suggest that Rock and Src act locally at the sites of blebbing to promote bleb formation. Both, active Src and active Rock (as evidenced by MLC phosphorylation) were clearly enriched in the bleb lumen. Because we failed to detect a bulk induction of pSrc or pMLC in SH4-domain-expressing cells (supplementary material Fig. S5A,B), SH4 domains might induce blebbing by recruiting these factors via direct or indirect mechanisms. Alternatively, SH4-domain expression might cause local activation of these kinases without elevating their global levels of activity. Irrespective of the detailed mechanism, our data suggest that local kinase activities govern bleb dynamics.
How might Src signalling regulate SH4-domain-induced PM blebbing? A recent study on the dynamics of molecular composition of M2 blebs provided evidence for the successive recruitment of ezrin, actin, bundling proteins and contractile proteins to retracting blebs (Charras et al., 2006
). Although not analyzed specifically, these observations suggest multiple possible scenarios of how Src could be involved in SH4-domain-induced blebbing. First, filamin is a substrate of Src kinases such as Lck and Src that can regulate its activity (Pal Sharma and Goldmann, 2004
). Our analysis excluded global changes in filamin expression or its serine phosphorylation (supplementary material Fig. S5C); however, SH4 domains might downmodulate filamin activity via tyrosine phosphorylation by recruited Src. In this scenario, SH4 domains would use a different molecular mechanism to create a situation that is functionally equivalent to that in M2 cells. Second, ezrin, which stabilizes membrane-actin crosslinks in M2 blebs (Charras et al., 2006
), is also subject to regulation by Src (Elliott et al., 2004
; Srivastava et al., 2005
). Finally, bleb retraction might be governed by actin nucleation events mediated by members of the Diaphanous-related formin protein family (Faix and Grosse, 2006
; Eisenmann et al., 2007
; Kitzing et al., 2007
), proteins that also functionally cooperate with Src (Gasman et al., 2003
; Koka et al., 2005
; Tominaga et al., 2000
). Current work in our laboratory attempts to differentiate between these possibilities.
Interestingly, Src is, in addition to the SH4-domain-induced blebbing motility described herein, also involved in the formation of invadopodia and podosome cell protrusions that facilitate cell invasion (Artym et al., 2006
; Buccione et al., 2004
; Hauck et al., 2002
; Linder and Aepfelbacher, 2003
; Tarone et al., 1985
; Wyckoff et al., 2006
). These structures mediate cell motility in 3D by promoting degradation of the extracellular matrix in a Rock-independent manner and are morphologically distinct from the PM blebs observed herein. Our study therefore suggests that Src kinases can promote 3D cell motility via several, fundamentally different, mechanisms. Together, the results presented here show that SH4 domains support bleb-associated cell motility by modulating PM dynamics in an Src-dependent manner. This novel activity of SH4 domains warrants future investigations on their role in bleb-associated motility of tumour cells.
| Materials and Methods |
|---|
|
|
|---|
myr-HASPB-GFP and CHO-N18-
palm-HASPB-GFP cell lines have already been described along with the description of quantitative protein expression-level analysis by western blotting and flow cytometry (Engling et al., 2002
Myr-GFP as well as the full-length HASPB, HASPB-GFP and N18-HASPB-mCherry were generated by subcloning the respective coding sequences into pREV-TRE2. Expression plasmids for mCherry (Shaner et al., 2004
Antibodies and reagents
Antibodies used were as follows: mouse anti
-tubulin clone B-5-1-2 (Sigma), mouse anti c-Src clone B-12 (Santa Cruz), rabbit anti Src (pY418) (Biosource), rabbit anti MLC2 (Cell Signaling), rabbit anti MLC (pS19) (Cell Signaling), mouse anti filamin 1 clone PM6/317 (Santa Cruz), rabbit anti filamin A (S2152) (Cell Signaling), goat anti mouse IgG Alexa-Fluor-568 (Invitrogen), goat anti rabbit IgG Alexa-Fluor-568 (Invitrogen), goat anti mouse IgG Alexa-Fluor-660 (Invitrogen). Reagents used were as follows: Alexa-Fluor-660 phalloidin (Invitrogen), blebbistatin (Calbiochem), cytochalasin D (Calbiochem), DMSO (Merck), Doxicyline (Sigma), Hoechst 33258 (Sigma), LinMount (Linaris E6004) Nocodazole (Calbiochem), phalloidin-TRITC (Sigma), PP1 (Calbiochem), SU6656 (Calbiochem) and Y-27632 (Calbiochem).
Fixation, immunostainings and confocal microscopy
For F-actin staining, cells grown on coverslips were fixed for 10 minutes at 4°C with 3% PFA, washed in TBS (50 mM Tris, pH 7.5, 150 mM NaCl), permeabilized with TBS/0.1% Triton X-100 (1 minute, room temperature) and incubated for 1 hour with 0.5 µg/ml phalloidin-TRITC and 1 ng/ml Hoechst 33258 in TBS. For staining of Src, pSrc, MLC, pMLC and Myc-tagged GTPases, cells were fixed and permeabilized in the same way, but for staining of
-tubulin, cells were fixed and permeabilized simultaneously with 3% PFA/0.1% Triton X-100 (10 minutes, 4°C). Subsequently, cells were washed with TBS, blocked with TBS/1% BSA (20 minutes, room temperature) and incubated with anti-Myc or -
-tubulin (1 hour, room temperature) or anti-Src, pSrc, MLC or pMLC antibody (over night, 4°C) in TBS, respectively. Cells were subsequently washed three times with TBS and incubated for 1 hour with the respective fluorescently labelled secondary antibody (Alexa-Fluor-568 or -660) together with phalloidin (TRITC or Alexa-Fluor-660) and Hoechst 33258 in TBS. After these staining steps, coverslips were washed with TBS before mounting on glass slides with LinMount and stored at 4°C. Apoptosis was analyzed by TUNEL assay using the in situ cell death detection kit, TMR red (Roche Applied Science) according to the manufacturer's instructions. Pictures of living cells in Lab-Tek chamber slides (nunc) and fixed cells on coverslips were taken from a bleb-rich middle section. Images were taken with a LSM 510 confocal laser scanning microscope (Zeiss) using 63x and 100x oil immersion objectives, respectively, and processed using Adobe Photoshop.
Real-time imaging and analysis
2D and 3D real-time sequences were acquired using a PerkinElmer Life and Analytical Sciences Ultraview LCI spinning disc confocal (Boston) mounted on a Nikon Eclipse TE200 microscope stand equipped with a Nikon Plan Apo 60x 1.4NA oil objective. The microscope was kept at 37°C by a microscope incubator box (EMBL Heidelberg). Time-lapses of single sections were acquired for up to 10 minutes with 150 ms exposure time (6.6 fps) using binning 1x1. 4D series were acquired for up to 15 minutes with 50 ms exposure time per section and a step size of 0.5 µm between sections covering the whole cell body. Kymographs of the 2D real-time sequences were created using ImageJ (http://rsb.info.nih.gov/ij/index.html) plugins as described (Pepperkok et al., 2005
) using only steps 6-8 in the section `Analyzing the Kinetics of Transport Carriers'. Visualization of 4D data was done using Imaris (Bitplane).
Scanning electron microscopy
For scanning electron microscopy (SEM), cells were fixed with 2.5% glutaraldehyde (v/v) in 0.1 M PBS with 1% sucrose (w/v), dehydrated in a graded series of ethanol and critical-point dried using carbon dioxide. Afterwards, cells were rotary-coated by electron beam evaporation using a BAF 300 freeze-etching device (Bal-Tec) with a single layer of platinum-carbon (coating thickness 3 nm). The samples were imaged in a Hitachi S-5200 in-lens field emission scanning electron microscope at an accelerating voltage of 4 kV using the secondary electron signal.
Transient expression of both wild-type and mutant forms of various GTPases and their effects on plasma membrane blebbing
All GTPases used were expressed as fusion proteins with GFP. In order to analyze HASPB-dependent blebbing under these conditions, N18-HASPB was co-transfected as a fusion protein with the red fluorescent protein mCherry (Shaner et al., 2004
). Cells were seeded on six-well plates and grown to a confluency of about 80%. For transient expression, cells were transfected with the constructs indicated using the calcium phosphate method (MBS transfection system; Stratagene). Transfected cells were passaged 24 hours post-transfection and transferred to microwell culture dishes (MatTek) to allow for in vivo imaging (48 hours post-transfection).
Drug treatment
Transgene expression was induced with 1 µg/ml dox in N18-HASPB-GFP cells growing on glass coverslips for 24 hours. To synchronize PM bleb formation, membrane blebbing was efficiently abrogated by treatment with 90 µM Y-27632 for 2 hours. After extensive washing of the cells, de novo bleb formation was allowed for 3 hours in dox-supplemented medium containing a solvent control or 90 µM Y-27632, 100 µM blebbistatin, 1 µM cytochalasin D, 1-10 µM PP1, 1-10 µM SU6656, 100 µM Nocodazole. Subsequently, the cells were fixed and stained for F-actin or
-tubulin. Apoptosis was induced by incubation of cells with Etoposide (200 µg/ml) and cycloheximide (200 µg/ml) overnight.
Invasion assay
Transwell assays were performed as described previously (Hooper et al., 2006
). Briefly, transwell membranes (pore size 8 µm) (Greiner Bio-One) were coated with 20 µl of undiluted growth-factor-reduced matrigel (BD Biosciences). For the analysis of inducible CHO cell lines, cells were kept in the presence of 1 µg/ml dox throughout. Following 12 hours dox induction in the presence of 10% FCS, cells were starved for 12 hours, harvested and counted. 106 cells were seeded in the upper chamber of the transwell in medium supplemented with 0.5% serum. The lower chamber was filled with medium supplemented with 10% serum. After 48 hours incubation at 37°C, cells in the upper chamber were carefully removed with a cotton swab and the cells that had traversed the membrane were fixed with 4% PFA, stained with Hoechst 33258 and counted at the microscope (Leica DMIRE2). To account for potential differences in cell seeding and/or proliferation during the 48 hours invasion period, cells were also plated in parallel in culture plates without matrigel, fixed at the time-point of harvest of the invasion samples and stained with Hoechst 33258 for chromatin. The number of nuclei in five representative areas was quantified and the number of invaded cells was normalized to the total number of cells. Maximum differences in cell numbers observed were 1.5-fold in parallel assays and increased cell proliferation observed in individual experiments was not correlated with the expression of any of the transgenes analyzed.
Confocal microscopy and 3D reconstructions
3D analyses were performed as described (Kitzing et al., 2007
). Briefly, CHO cells stably expressing N18-HASPB-GFP were transfected with an mRFP-actin expression plasmid. 24 hours later, cells were counted and seeded directly into matrigel (BD Biosciences) and placed into µ-Slide VI chambers (ibidi). Cell morphologies were analyzed by taking z intervals of 1 µm with a 40x objective using confocal microscopy (Leica TCS SP2). 3D reconstructions and animations of the z-sections were performed using Leica Confocal Simulator Software.
SDS-PAGE and western blotting
6x105 cells seeded in a 6 cm dish were treated with 1 µg/ml dox for 24 hours. The cells were lysed in 250 µl Rock lysis buffer (Coleman et al., 2001
), the total protein amounts were detected using a BCA detection kit according to the manufacturer's instructions and, after addition of 50 µl 6xSDS sample buffer, the lysates were boiled at 100°C for 5 minutes. For SDS-PAGE, 40-50 µg of total protein was loaded. After transferring the proteins to a PVDF membrane, the membranes were blocked for 30 minutes with 5% milk in TBS-T (TBS + 1% Tween-20) before they were incubated over night with antibodies directed against the protein of interest. Secondary antibodies were either coupled to horse radish peroxidase for ECL detection or to Alexa-Fluor-688 antibodies for detection with the Odyssey infrared imaging system (LI-COR Biosciences).
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Artym, V. V., Zhang, Y., Seillier-Moiseiwitsch, F., Yamada, K. M. and Mueller, S. C. (2006). Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 66, 3034-3043.
Buccione, R., Orth, J. D. and McNiven, M. A. (2004). Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5, 647-657.[CrossRef][Medline]
Charras, G. T., Yarrow, J. C., Horton, M. A., Mahadevan, L. and Mitchison, T. J. (2005). Non-equilibration of hydrostatic pressure in blebbing cells. Nature 435, 365-369.[CrossRef][Medline]
Charras, G. T., Hu, C. K., Coughlin, M. and Mitchison, T. J. (2006). Reassembly of contractile actin cortex in cell blebs. J. Cell Biol. 175, 477-490.
Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A. and Olson, M. F. (2001). Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.[CrossRef][Medline]
Cunningham, C. C. (1995). Actin polymerization and intracellular solvent flow in cell surface blebbing. J. Cell Biol. 129, 1589-1599.
Denny, P. W., Gokool, S., Russell, D. G., Field, M. C. and Smith, D. F. (2000). Acylation-dependent protein export in Leishmania. J. Biol. Chem. 275, 11017-11025.
Eisenmann, K. M., Harris, E. S., Kitchen, S. M., Holman, H. A., Higgs, H. N. and Alberts, A. S. (2007). Dia-interacting protein modulates formin-mediated actin assembly at the cell cortex. Curr. Biol. 17, 579-591.[CrossRef][Medline]
Elliott, B. E., Qiao, H., Louvard, D. and Arpin, M. (2004). Co-operative effect of c-Src and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells. J. Cell. Biochem. 92, 16-28.[CrossRef][Medline]
Engling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S. and Nickel, W. (2002). Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J. Cell Sci. 115, 3619-3631.
Faix, J. and Grosse, R. (2006). Staying in shape with formins. Dev. Cell 10, 693-706.[CrossRef][Medline]
Fishkind, D. J., Cao, L. G. and Wang, Y. L. (1991). Microinjection of the catalytic fragment of myosin light chain kinase into dividing cells: effects on mitosis and cytokinesis. J. Cell Biol. 114, 967-975.
Frame, M. C. (2004). Newest findings on the oldest oncogene; how activated src does it. J. Cell Sci. 117, 989-998.
Gasman, S., Kalaidzidis, Y. and Zerial, M. (2003). RhoD regulates endosome dynamics through Diaphanous-related Formin and Src tyrosine kinase. Nat. Cell Biol. 5, 195-204.[CrossRef][Medline]
Gasteier, J. E., Madrid, R., Krautkramer, E., Schroder, S., Muranyi, W., Benichou, S. and Fackler, O. T. (2003). Activation of the Rac-binding partner FHOD1 induces actin stress fibers via a ROCK-dependent mechanism. J. Biol. Chem. 278, 38902-38912.
Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
Hauck, C. R., Hsia, D. A., Ilic, D. and Schlaepfer, D. D. (2002). v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem. 277, 12487-12490.
Hooper, S., Marshall, J. F. and Sahai, E. (2006). Tumor cell migration in three dimensions. Meth. Enzymol. 406, 625-643.[Medline]
Kaplan, J. M., Mardon, G., Bishop, J. M. and Varmus, H. E. (1988). The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. Mol. Cell. Biol. 8, 2435-2441.
Kitzing, T. M., Sahadevan, A. S., Brandt, D. T., Knieling, H., Hannemann, S., Fackler, O. T., Grosshans, J. and Grosse, R. (2007). Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev. 21, 1478-1483.
Koka, S., Minick, G. T., Zhou, Y., Westendorf, J. J. and Boehm, M. B. (2005). Src regulates the activity of the mammalian formin protein FHOD1. Biochem. Biophys. Res. Commun. 336, 1285-1291.[CrossRef][Medline]
Lane, J. D., Allan, V. J. and Woodman, P. G. (2005). Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell Sci. 118, 4059-4071.
Leverrier, Y. and Ridley, A. J. (2001). Apoptosis: caspases orchestrate the ROCK `n' bleb. Nat. Cell Biol. 3, E91-E93.[CrossRef][Medline]
Linder, S. and Aepfelbacher, M. (2003). Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 13, 376-385.[CrossRef][Medline]
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A. and Surprenant, A. (2001). Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15, 825-835.[CrossRef][Medline]
McCabe, J. B. and Berthiaume, L. G. (1999). Functional roles for fatty acylated amino-terminal domains in subcellular localization. Mol. Biol. Cell 10, 3771-3786.
Mills, J. C., Stone, N. L., Erhardt, J. and Pittman, R. N. (1998). Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J. Cell Biol. 140, 627-636.
Moreau, V., Frischknecht, F., Reckmann, I., Vincentelli, R., Rabut, G., Stewart, D. and Way, M. (2000). A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2, 441-448.[CrossRef][Medline]
Morelli, A., Chiozzi, P., Chiesa, A., Ferrari, D., Sanz, J. M., Falzoni, S., Pinton, P., Rizzuto, R., Olson, M. F. and Di Virgilio, F. (2003). Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell 14, 2655-2664.
Pacholsky, D., Vakeel, P., Himmel, M., Lowe, T., Stradal, T., Rottner, K., Furst, D. O. and van der Ven, P. F. (2004). Xin repeats define a novel actin-binding motif. J. Cell Sci. 117, 5257-5268.
Pal Sharma, C. and Goldmann, W. H. (2004). Phosphorylation of actin-binding protein (ABP-280; filamin) by tyrosine kinase p56lck modulates actin filament cross-linking. Cell Biol. Int. 28, 935-941.[CrossRef][Medline]
Pepperkok, R., Simpson, J. C., Rietdorf, J., Cetin, C., Liebel, U., Terjung, S. and Zimmermann, T. (2005). Imaging platforms for measurement of membrane trafficking. Meth. Enzymol. 404, 8-18.[Medline]
Resh, M. D. (1994). Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76, 411-413.[CrossRef][Medline]
Sahai, E. and Marshall, C. J. (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719.[CrossRef][Medline]
Sebbagh, M., Renvoize, C., Hamelin, J., Riche, N., Bertoglio, J. and Breard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346-352.[CrossRef][Medline]
Shaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B. N., Palmer, A. E. and Tsien, R. Y. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22, 1567-1572.[CrossRef][Medline]
Sheetz, M. P., Sable, J. E. and Dobereiner, H. G. (2006). Continuous membrane-cytoskeleton adhesion requires continuous accommodation to lipid and cytoskeleton dynamics. Annu. Rev. Biophys. Biomol. Struct. 35, 417-434.[CrossRef][Medline]
Sigal, C. T., Zhou, W., Buser, C. A., McLaughlin, S. and Resh, M. D. (1994). Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc. Natl. Acad. Sci. USA 91, 12253-12257.
Srivastava, J., Elliott, B. E., Louvard, D. and Arpin, M. (2005). Src-dependent ezrin phosphorylation in adhesion-mediated signaling. Mol. Biol. Cell 16, 1481-1490.
Stegmayer, C., Kehlenbach, A., Tournaviti, S., Wegehingel, S., Zehe, C., Denny, P., Smith, D. F., Schwappach, B. and Nickel, W. (2005). Direct transport across the plasma membrane of mammalian cells of Leishmania HASPB as revealed by a CHO export mutant. J. Cell Sci. 118, 517-527.
Straight, A. F., Cheung, A., Limouze, J., Chen, I., Westwood, N. J., Sellers, J. R. and Mitchison, T. J. (2003). Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299, 1743-1747.
Tarone, G., Cirillo, D., Giancotti, F. G., Comoglio, P. M. and Marchisio, P. C. (1985). Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp. Cell Res. 159, 141-157.[CrossRef][Medline]
Thomas, S. M. and Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513-609.[CrossRef][Medline]
Tominaga, T., Sahai, E., Chardin, P., McCormick, F., Courtneidge, S. A. and Alberts, A. S. (2000). Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol. Cell 5, 13-25.[CrossRef][Medline]
Torgerson, R. R. and McNiven, M. A. (1998). The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing. J. Cell Sci. 111, 2911-2922.[Abstract]
Wolf, K., Muller, R., Borgmann, S., Brocker, E. B. and Friedl, P. (2003). Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102, 3262-3269.
Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S. and Sahai, E. (2006). ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 16, 1515-1523.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
O. T. Fackler and R. Grosse Cell motility through plasma membrane blebbing J. Cell Biol., June 16, 2008; 181(6): 879 - 884. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||